Moreover, the level of SFRP1 was significantly higher in tumour samples obtained from patients with stage III NSCLC compared to tumour samples obtained from patients with stage II (644.83 vs. 204.38; p = 0.012). The gene discussed is SFRP1; the disease is neoplasm.